InChI=1S/C16H27NO6/c1- 11(2) 14(20) 22- 12(3) 23- 15(21) 17- 10- 16(9- 13(18) 19) 7- 5- 4- 6- 8- 16/h11- 12H,4- 10H2,1- 3H3,(H,17,21) (H,18,19) |
TZDUHAJSIBHXDL-UHFFFAOYSA-N |
CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
|
|
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
anticonvulsant
A drug used to prevent seizures or reduce their severity.
|
|
View more via ChEBI Ontology
{1-[({[1-(isobutyryloxy)ethoxy]carbonyl}amino)methyl]cyclohexyl}acetic acid
|
gabapentin enacarbil
|
KEGG DRUG
|
gabapentina enacarbilo
|
WHO MedNet
|
gabapentine enacarbil
|
WHO MedNet
|
gabapentinum enacarbilum
|
WHO MedNet
|
XP 13512
|
ChemIDplus
|
XP-13512
|
ChemIDplus
|
XP13512
|
ChemIDplus
|
10188772
|
Reaxys Registry Number
|
Reaxys
|
478296-72-9
|
CAS Registry Number
|
ChemIDplus
|
|